CARICE Ageing and Long-term conditions Seminars - November 2024
You can join the seminar via teams or click the link in the right hand column
If you would like to have a monthly invitation in your calendar, please email victoria.vazquez@kcl.ac.uk
Dr Chiara Herzog
2024 King’s Prize Fellow at King’s College London
Talk title: “Leveraging omic biomarkers to predict disease risk and understand ageing"
Recent technological advances in molecular profiling allow us to identify biomarkers that could predict disease risk before symptoms arise. Here, I will share insights from my research into epigenetic and omic biomarkers, highlight findings from human intervention studies, and outline my future research vision.
Dr Chiara Herzog is a 2024 King’s Prize Fellow at King’s College London. Her research focuses on identifying new biomarkers that can capture environmental exposures and stratify individuals based on their risk for age-related diseases, particularly through epigenetics. Her efforts have led to multiple high-impact publications, numerous awards, and a clinically available test for uterine cancer. As an Executive Committee Member of the Biomarkers of Aging Consortium, she is dedicated to promoting the standardisation of ageing biomarkers to enhance their clinical utility. At KCL, she will investigate causal molecular changes linked to ageing and disease, utilising data from both population-based studies and cellular models.
Dr Matthew Adesuyan
Lead Population Health Pharmacist at GSTT
Talk title: "Beyond Erectile Dysfunction: Could PDE5-Inhibitors Influence Alzheimer’s Disease Risk?"
A wealth of data is contained in electronic health records (EHR), which can be used for multiple research purposes including hypothesis-testing studies. In this talk, Dr Adesuyan will present findings from a retrospective cohort study that utilised pseudonymised EHR.
Dr Matthew Adesuyan is the Lead Population Health Pharmacist at GSTT and has recently completed his PhD in Pharmacoepidemiology at UCL School of Pharmacy. His research focuses on leveraging real-world data from electronic health records (EHR) to investigate the safe and effective use of medicines in large populations, with a particular focus on the connection between cardiovascular health and neurodegenerative diseases.
Search for another event